RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
RARITAN, NJ--(Marketwired - Aug 18, 2015) - Ortho Clinical Diagnostics today announced that it obtained 510(k) clearance for the ORTHO VISION™ Analyzer, a highly interactive, fully automated analyzer ...
RARITAN, NJ--(Marketwired - Oct 14, 2015) - Ortho Clinical Diagnostics today announced ORTHO VISION™ Max, a fully automated blood analyser for high-volume transfusion medicine laboratories, received ...
Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained CE Mark (Conformité Européenne) for the ORTHO VISION™ Analyzer, a highly interactive, fully automated analyzer for transfusion ...
Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION TM Analyzer, a highly interactive, fully automated analyzer ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...